Losartan Butyl Ether | CAS 2204442-78-2 - Request Quote
Losartan Butyl Ether
| SZ CAT No: | SZ-L028043 |
| CAS No | 2204442-78-2 |
| Mol.F. | C26H31ClN6O |
| Mol.Wt. | 479.0 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Losartan Butyl Ether is chemically 5-(4'-((5-(butoxymethyl)-2-butyl-4-chloro-1H-imidazol-1-yl)methyl)-[1,1'-biphenyl]-2-yl)-1H-tetrazole. Losartan Butyl Ether is supplied with detailed characterization data compliant with regulatory guideline. Losartan Butyl Ether can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Losartan.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 2204442-78-2
Purchase 2204442-78-2
Order 2204442-78-2
Enquire 2204442-78-2
price of 2204442-78-2
2204442-78-2 Supplier
2204442-78-2 Manufacturer
2204442-78-2 Exporter
buy high quality Losartan Butyl Ether
Purchase Losartan Butyl Ether
Losartan Butyl Ether suppliers
Losartan Butyl Ether manufacturers
Losartan Butyl Ether price
Order Losartan Butyl Ether
Enquire Losartan Butyl Ether
Losartan Butyl Ether cost
Losartan Butyl Ether Supplier
Losartan Butyl Ether Distributor
Losartan Butyl Ether for Method Validation
Losartan Reference Standard
Losartan Butyl Ether for ANDA Filing
Losartan Butyl Ether for Forced Degradation Studies
Losartan Butyl Ether Identification Standards
Losartan Butyl Ether for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.